STEMO deployment incurred no increased risk for intracerebral hemorrhage ( STEMO deployment : 7/200 ; conventional care : 22/323 ; adjusted odds ratio [ OR ] , 0.42 , 95 % CI , 0.18-1 .03 ; P = .06 ) or 7-day mortality ( 9/199 vs 15/323 ; adjusted OR , 0.76 ; 95 % CI , 0.31-1 .82 ; P = .53 ) .